Device |
hospital continuous glucose monitoring system |
Regulation Description |
Glucose test system. |
Definition |
Intended for the continuous, quantitative measurement of glucose in whole blood in a hospital setting. |
Physical State |
The device system is comprised of a cartridge and an instrument that measures and displays the result. |
Technical Method |
The operator connects the device to the blood source of the patient and activates the assay. |
Target Area |
Whole blood. |
Regulation Medical Specialty |
Clinical Chemistry |
Review Panel |
Clinical Chemistry |
Product Code | PYV |
Premarket Review |
Office of In Vitro Diagnostics
(OHT7)
Division of Chemistry and Toxicology Devices
(DCTD)
|
Submission Type |
510(k)
|
Regulation Number |
862.1345
|
Device Class |
2
|
Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
GMP Exempt? |
No
|
Summary Malfunction Reporting |
Ineligible |
Implanted Device? |
No
|
Life-Sustain/Support Device? |
No
|
Third Party Review |
Not Third Party Eligible |